Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2000
09/21/2000WO2000055307A2 A method for increasing the processivity of a dna- or rna-dependent polymerase and compositions therefor
09/21/2000WO2000055305A1 Method of isolating cd8+ cells, and related hybridoma cells, antibodies and polypeptides
09/21/2000WO2000055304A2 A chc biosynthetic gene cluster
09/21/2000WO2000055303A2 Transgenic plants having imroved flavor properties
09/21/2000WO2000055302A2 Genetically modified plants having modulated brassinosteroid signaling
09/21/2000WO2000055301A2 Method for inducing viral resistance into a plant
09/21/2000WO2000055207A1 A novel chimeric protein for prevention and treatment of hiv infection
09/21/2000WO2000055205A1 ISOFORMS OF MOUSE SEROTONIN 5-HT2c RECEPTOR
09/21/2000WO2000055201A1 49 human secreted proteins
09/21/2000WO2000055200A1 50 human secreted proteins
09/21/2000WO2000055199A1 47 human secreted proteins
09/21/2000WO2000055198A1 50 human secreted proteins
09/21/2000WO2000055197A1 Novel proteins and uses thereof
09/21/2000WO2000055194A2 Tuberculosis antigens and methods of use therefor
09/21/2000WO2000055192A2 Hemocyanin and nucleic acid sequence coding for the same
09/21/2000WO2000055191A2 Recombinant haemophilus influenzae adhesin proteins
09/21/2000WO2000055180A2 Human lung cancer associated gene sequences and polypeptides
09/21/2000WO2000055178A1 INSECT p53 TUMOR SUPPRESSOR GENES AND PROTEINS
09/21/2000WO2000055177A2 49 human secreted proteins
09/21/2000WO2000055176A2 49 human secreted proteins
09/21/2000WO2000055175A1 50 human secreted proteins
09/21/2000WO2000055174A1 Human prostate cancer associated gene sequences and polypeptides
09/21/2000WO2000055173A1 Human breast and ovarian cancer associated gene sequences and polypeptides
09/21/2000WO2000055172A1 Plants having modified reproductive capacity
09/21/2000WO2000055171A1 50 human secreted proteins
09/21/2000WO2000055169A1 TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS
09/21/2000WO2000054882A1 Individually addressable micro-electromagnetic unit array chips
09/21/2000WO2000054815A2 Expression of dna or proteins in c. elegans
09/21/2000WO2000054806A1 Insulin-like growth factor binding protein-4 protease
09/21/2000WO2000054796A1 Novel antiangiogenic peptides
09/21/2000WO2000054770A1 Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis
09/21/2000WO2000054731A2 Syndesmos and uses thereof
09/21/2000WO2000054595A1 Recombinant adeno-associated virus transfer of genes affecting demyelination
09/21/2000WO2000054580A2 Leukotriene b4 receptor transgenic mammals
09/21/2000WO2000054574A2 Chemical and physical treatment that stimulate recombination
09/21/2000WO2000054573A1 Geminivirus resistant transgenic plants
09/21/2000WO2000040751A3 Detecting nucleic acids
09/21/2000WO2000040739A3 RIBONUCLEOTIDE REDUCTASE LARGE SUBUNIT (R1) cDNA AND USES THEREOF
09/21/2000WO2000040716A3 Soluble receptor br43x2 and methods of using them for therapy
09/21/2000WO2000040603A3 Production of recombinant monellin using methylotrophic yeast expression system
09/21/2000WO2000039303A3 Modified hiv env polypeptides
09/21/2000WO2000039292A3 Antisense oligonucleotide for inhibiting the expression of the adhesion molecule very late antigen 4 (vla-4) in human cells
09/21/2000WO2000029846A9 COMPOSITIONS AND METHODS RELATING TO THE PEROXISOMAL PROLIFERATOR ACTIVATED RECEPTOR-α MEDIATED PATHWAY
09/21/2000WO2000029587A8 Thermostable xylanases
09/21/2000WO2000027868A3 Connective tissue growth factor (ctgf) and methods of use
09/21/2000WO2000026340A9 Novel nucleic acid molecules encoding opioid growth factor receptors
09/21/2000WO2000026237A3 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof
09/21/2000WO2000026227A9 Ldl related protein and uses thereof
09/21/2000WO2000025800A9 Steroid receptor rna activator
09/21/2000WO2000024912A9 Use of a self-cleaving rna motif to modulate gene expression
09/21/2000WO2000024898A8 Gene for a thrombin inhibitor from the triatoma genus and protein with a thrombin-inhibiting effect
09/21/2000WO2000023579A9 Functionally assembled antigen-specific intact recombinant antibody and a method for production thereof
09/21/2000WO2000022115A3 Assays for identifying functional alterations in the p53 tumor suppressor
09/21/2000WO2000022095A3 Method and apparatus for direct in vivo gene transfer by electrotransfection
09/21/2000WO2000022001A3 A potassium channel of the erg family
09/21/2000WO2000021989A9 Decorin binding proteins dbp a and b and genes encoding them
09/21/2000WO2000020598A9 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock
09/21/2000WO2000020574A3 Fusions of scaffold proteins with random peptide libraries
09/21/2000WO2000020571A3 Maize promoters
09/21/2000WO2000020557A9 Gemini virus vectors for gene expression in plants
09/21/2000WO2000020039A9 Methods and adjuvants for stimulating mucosal immunity
09/21/2000WO2000018783A9 Mammaglobin, a secreted mammary-specific breast cancer protein
09/21/2000WO2000017334A3 Analysis of ligand activated nuclear receptors i(in vivo)
09/21/2000WO2000016746A9 Immunogenic liposome compositions
09/21/2000WO2000015792A3 Promotion or inhibition of angiogenesis and cardiovascularization
09/21/2000WO2000010602A9 Lats knock-out animal models and their uses
09/21/2000WO2000007427A3 Method for selective and optionally reversible degeneration of somatic plant tissue
09/21/2000DE19918023A1 Preparation of a liver cell-derived packaging cell line comprises stabile transfection of adenoviral E1 sequences of human hepatoma cells
09/21/2000DE19912502A1 Nanoskalige Teilchen, Komplexe mit Polynukleotiden und deren Verwendung Nanoscale particles, complexes with polynucleotides and their use
09/21/2000DE19912384A1 Verfahren zur fermentativen Herstellung von L-Aminosäuren unter Verwendung coryneformer Bakterien A process for the fermentative preparation of L-amino acids using coryneform bacteria
09/21/2000DE19910912A1 New human RET proto-oncogene variants for determining disease disposition and tailoring specific individual therapies, for e.g. multiple endocrine neoplasia syndrome type 2A or for familial medullary thyroid gland carcinoma
09/21/2000DE19910650A1 Auf HERV-LTR-Sequenzen basierende retrovirale Expressionsvektoren Based on HERV LTR sequences retroviral expression vectors
09/21/2000DE19910419A1 Zielzellspezifische, multivalente Proteine (MVP) Target cell-specific, multivalent proteins (MVP)
09/21/2000DE19853778C1 DNA-Sequenzen kodierend einen Glutamat/Malat-Translokator, Plasmide Bakterien, Hefen und Pflanzen enthaltend diesen Transporter DNA sequences encoding a glutamate / malate translocator, plasmids, bacteria, yeasts and plants containing these transporters
09/21/2000CA2369319A1 Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
09/21/2000CA2368109A1 Detection of melanoma
09/21/2000CA2368068A1 27 human secreted proteins
09/21/2000CA2367906A1 Tcl-1b gene and protein and related methods and compositions
09/21/2000CA2367648A1 Recombinant adeno-associated virus transfer of genes affecting demyelination
09/21/2000CA2367611A1 Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis
09/21/2000CA2367213A1 Novel antiangiogenic peptides
09/21/2000CA2367160A1 Leukotriene b4 receptor transgenic mammals
09/21/2000CA2366929A1 Making and using microclonal uncloned cdna libraries
09/21/2000CA2366866A1 Electropolymerizable film, and method of making and use thereof
09/21/2000CA2366839A1 Microbial .beta.-glucuronidase genes, gene products and uses thereof
09/21/2000CA2366195A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
09/21/2000CA2366174A1 Human colon cancer associated gene sequences and polypeptides
09/21/2000CA2366130A1 Human cancer associated gene sequences and polypeptides
09/21/2000CA2366054A1 Lentiviral vector system for high quantity screening
09/21/2000CA2365668A1 In vitro macromolecule biosynthesis methods using exogenous amino acids and a novel atp regeneration system
09/21/2000CA2365655A1 Retrovirus producting cells utilizing a high multiplicity of transduction
09/21/2000CA2365645A1 Improved expression vector for consistent cellular expression of the tet on repressor in multiple cell types
09/21/2000CA2365451A1 Nucleic acid molecule comprising a nucleic acid sequence coding for a hemocyanin
09/21/2000CA2365279A1 Genetically modified plants with altered starch
09/21/2000CA2365263A1 A method for increasing the processivity of a dna- or rna-dependent polymerase and compositions therefor
09/21/2000CA2365214A1 Vertebrate protein slit, dna sequence encoding it and uses thereof
09/21/2000CA2365125A1 Probe/mobility modifier complexes for multiplex nucleic acid detection
09/21/2000CA2365123A1 Mismatch repair detection
09/21/2000CA2365102A1 Neisseria meningitidis antigenic polypeptides and encoding polynucleotides and uses thereof
09/21/2000CA2365096A1 Polyunsaturated fatty acid (pufa) elongase from caenorhabditis elegans
1 ... 3182 3183 3184 3185 3186 3187 3188 3189 3190 3191 3192 3193 3194 3195 3196 3197 3198 3199 3200 3201 3202 ... 4023